Funded Startups in Kyonggi-do
Among the 21 most recent Kyonggi-do entries, disclosed round sizes cluster between $330K and $234M, but one disclosed outlier stands out: SK Eternix raised…
Among the 21 most recent Kyonggi-do entries, disclosed round sizes cluster between $330K and $234M, but one disclosed outlier stands out: SK Eternix raised $234M on 2026-03-06, far above the next-largest disclosed amounts ($135M for XCENA on 2026-05-29 and $100M for KoMiCo on 2026-05-18). Stages are skewed toward “Series Unknown” and undisclosed disclosures: 8 of 21 rows list “undisclosed” amounts and 12 of 21 rows list “Series Unknown,” with only three clearly labeled seeds/early rounds (EduSync on 2026-04-06; Watt on 2026-04-03) and a smaller number of named later-stage rounds (e.g., Series C for Nexusbe on 2026-06-18 and Solivis on 2026-06-04). Geographically, Seongnam appears repeatedly across multiple tech-leaning categories (e.g., Huons BioPharma on 2026-06-23, XCENA on 2026-05-29, and SK Eternix on 2026-03-06), while the date window spans 2026-03-06 through 2026-06-23, keeping the activity concentrated within roughly three and a half months. Sector-wise, AI shows up in multiple entries (Metainnotech, Alchera, Funzin, and Retriever), alongside Biotechnology (LabGenomics and SN BioScience).
Most recent rounds
21 shownRelated listings
Frequently asked
Which disclosed round is the size outlier, and how does it compare to other disclosed amounts in this Kyonggi-do list?
SK Eternix’s $234M round (2026-03-06) is the only disclosed amount above $200M in the shown rows, and it dwarfs the next-largest disclosed amounts at $135M (XCENA, 2026-05-29) and $100M (KoMiCo, 2026-05-18).
How concentrated is the activity by date across these 21 most recent entries?
The round dates run from 2026-03-06 (SK Eternix, $234M) to 2026-06-23 (Huons BioPharma, undisclosed), so the list covers about three and a half months with multiple late-June rounds (e.g., Nexusbe on 2026-06-18 and Metainnotech on 2026-06-15).
Are there stage or disclosure patterns that limit how comparable these rounds are?
Disclosure is uneven: 8 of 21 entries show “undisclosed” amounts, and 12 of 21 are labeled “Series Unknown” (for example, Huons BioPharma on 2026-06-23 and Metainnotech on 2026-06-15). Even among named stages, large disclosed rounds cluster in Series C (Nexusbe $7M on 2026-06-18; Solivis $14M on 2026-06-04) while very large disclosed sizes appear under “Series Unknown” (KoMiCo $100M on 2026-05-18; SK Eternix $234M on 2026-03-06).
Which sectors recur most often, and do those repeats coincide with specific stages or cities?
Artificial Intelligence appears in four entries: Metainnotech (AI, Series Unknown, 2026-06-15; $3M), Retriever (AI, Series Unknown, 2026-06-09; $330K), Alchera (AI, Series Unknown, 2026-05-15; $3M), and Funzin (AI, Series Unknown, 2026-05-07; $2M). Biotechnology also repeats (LabGenomics on 2026-06-08; $13M, and SN BioScience on 2026-04-07; $9M), both in Kyonggi-do locations tied to Seongnam-area listings (LabGenomics is in Bundangdong; SN BioScience is in Seongnam).
Does the city pattern suggest one hub within Kyonggi-do appears more than others?
Seongnam is the most recurring city across the rows, including Huons BioPharma (2026-06-23), XCENA (2026-05-29; $135M), KoMiCo (2026-05-18; $100M), Wilco (2026-04-01; undisclosed), and SK Eternix (2026-03-06; $234M). Other cities like Paju (OSR Holdings, 2026-04-09; $560K) and Yongsin (Nexusbe, 2026-06-18; $7M) show up less frequently in this excerpt.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.